Skip to main content
. 2021 Jun 24;16(6):e0253879. doi: 10.1371/journal.pone.0253879

Table 1. Characteristics of patients with PTB and controls with LTBI (n = 81).

Variable PTB cases (n = 24) LTBI controls (n = 57) P value
Age, years 62.1±21.0 63.7±17.4 0.727
Male sex 17 (71) 30 (43) 0.028
BMI (kg/m2) 21.0±3.4 23.4±3.2 0.003
Ever smoker 15 (63) 16 (23) 0.003
Diabetes 6 (25) 12 (17) 0.680
Malignancy 4 (17) 4 (6) 0.187
CKD 1 (4) 2 (3) 1.000
BCG scar 18 (78) 53 (79) 1.000
IFN-γ (IU/mL)
    MTB-Ag–nil 5.30±3.73 2.78±2.91 0.005
    Mitogen–nil 7.63±3.04 9.35±1.37 0.005
Differential counts a
    Lymphocyte (k/mm3) 1.37±0.42 1.85±0.53 <0.001
    Monocyte (k/mm3) 0.68±0.36 0.51±0.21 0.006
    MLR 0.52±0.22 0.28±0.10 <0.001
qPCR Ct value 38.06 [35.73–45] 45.0 [45.0–45.0] <0.001

aFor two patients with LTBI, no data on blood differential count or MLR were available.

Abbreviations: BCG, Bacillus Calmette–Guérin vaccine; BMI, body mass index; CKD, chronic kidney disease; IFN-γ, interferon-gamma; MLR, monocyte to lymphocyte ratio; MTB-Ag, Mycobacterium tuberculosis–specific antigen stimulation; qPCR Ct value, quantitative polymerase chain reaction–derived cycle threshold value.